Instructions to Authors

ISPOR CONNECTIONS accepts articles on international or country-specific health care guidelines, policies, methodological issues, reviews related to pharmacoeconomics and outcomes research including economic, clinical study, or health-related quality-of-life study issues.

Manuscript submission: Authors should submit technical articles electronically as email attachments whenever possible. Regular mail or courier mail submissions should only be made when e-mail submissions are not possible, and should include the document in electronic form on disk.

All submissions should be addressed to:

ISPOR CONNECTIONS, ISPOR
3100 Princeton Pike, Suite 3E
Lawrenceville, NJ 08648
Email: isporconnections@ispor.org
fax 609-219-0774

Articles are to be approximately 2500-3000 words. Articles must be written in English, typed in either Microsoft Word (version 5.0 or later) or WordPerfect (version 5.1 or later). Documents are NOT to be sent as read-only documents.

By-line: All articles submitted are to have the article title, author(s), affiliation(s), city, state, and country included in the submission.

Tables and Figures: Tables and figures are encouraged mandatory, but are encouraged. They should be clearly labeled and easy to understand without reference to the text. Figures should be created using Word, Excel, or PowerPoint to be directly reproducible for publication.

References:
References, if any, should be listed and numbered consecutively in Arabic numerals in the order in which they are cited in the text. Reference style should follow that of Index Medicus.

Technical articles submitted MUST NOT contain any advertising, publicity, or promotion of any product by the author’s company. Press releases are not considered.
 


Back to ISPOR CONNECTIONS index page
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2010 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.